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Background: Papillary muscle rupture (PMR) is a rare, but often life-threatening mechanical complication of
myocardial infarction (MI). Immediate surgical intervention is considered the optimal and most rational treatment
for acute PMR, but carries high risks. At this point it is not entirely clear which patients are at highest risk. In this
study we sought to determine in-hospital mortality and its predictors for patients who underwent mitral valve
surgery for post-MI PMR.
Methods: Between January 1990 and December 2012, 48 consecutive patients (mean age 64.9 ± 10.8 years)
underwent mitral valve repair (n = 10) or replacement (n = 38) for post-MI PMR. Clinical data, echocardiographic
data, catheterization data, and surgical reports were reviewed. Univariate and multivariate logistic regression
analyses were performed to identify predictors of in-hospital mortality.
Results: Intraoperative mortality was 4.2% and in-hospital mortality was 25.0%. Univariate and multivariate logistic
regression analyses revealed the logistic EuroSCORE and EuroSCORE II as independent predictors of in-hospital
mortality. Receiver operating characteristics curves showed an optimal cutoff value of 40% for the logistic EuroSCORE
(area under the curve 0.85, 95% CI 0.71-1.00, P < 0.001) and of 25% for the EuroSCORE II (area under the curve 0.83, 95%
CI 0.68-0.99, P = 0.001). After removal of the EuroSCOREs from the model, complete PMR and intraoperative intra-aortic
balloon pump (IABP) requirement were independent predictors of in-hospital mortality.
Conclusions: The logistic EuroSCORE (optimal cutoff ≥40%), EuroSCORE II (optimal cutoff ≥25%), complete PMR, and
intraoperative IABP requirement are strong independent predictors of in-hospital mortality in patients undergoing
mitral valve surgery for post-MI PMR. These predictors may aid in surgical decision making and they may help improve
the quality of informed consent.
Keywords: Myocardial infarction, Papillary muscle (rupture), Mitral regurgitation, Mitral valve repair, Mitral valve
replacement, OutcomeBackground
Papillary muscle rupture (PMR) is a rare, but often
life-threatening mechanical complication of myocardial
infarction (MI) [1]. It occurs in 1% to 5% of patients with
acute MI and accounts for 5% of infarct-related deaths
[1,2]. Approximately 80% of ruptures occur within 7 days* Correspondence: w.bouma@umcg.nl
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unless otherwise stated.after MI, but a delayed rupture several weeks or months
after MI is also possible [1-3]. When treated only medic-
ally, mortality may be as high as 50% in the first 24 hours
(especially when PMR is complete), and as high as 80% in
the first week [3,4]. Since the first mitral valve replace-
ment (MVR) for post-MI PMR in 1965 [5], several reports
have emphasized that immediate surgical intervention is
the optimal and most rational treatment for acute PMR,
despite high risks [2,3,6,7]. Although mitral valve repair
may lead to a better outcome due to a better preservation
of postoperative left ventricular function [8-13], MVR isLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Bouma et al. Journal of Cardiothoracic Surgery 2014, 19:171 Page 2 of 8
http://www.cardiothoracicsurgery.org/content/19/1/171generally preferred in these unstable, high-risk patients
[7,14-17]. Because of the high risk some surgeons may be
reluctant to operate these patients, while others are willing
to accept the high risk. At this point it is not entirely clear
which patients are at highest risk.
We present one of the largest series to date of patients
who underwent mitral valve surgery for post-MI PMR.
In this study we sought to determine in-hospital mortality
and its predictors. Identifying these predictors may aid the
surgical decision making process and it may help improve
the quality of informed consent.
Methods
This study was conducted in accordance with the
guidelines of the University Medical Center Groningen
Institutional Review Board.
Patients
Between January 1990 and December 2012, 48 consecutive
patients underwent mitral valve surgery for moderate
(grade 3+) or severe (grade 4+) mitral regurgitation (MR)
caused by post-MI PMR. Baseline patient characteristics
are summarized in Table 1. All patients had a documented
MI before PMR. Infarct location was determined elec-
trocardiographically and echocardiographically (by the
detection of wall motion abnormalities).
Clinical data, echocardiographic data, catheterization
data, and surgical reports were reviewed. Intraoperative
mortality was defined as death during surgery. In-hospital
mortality was defined as death during surgery, within
30 days after surgery or during the same hospital stay.
Follow-up was complete.
Echocardiography and coronary angiography
All patients underwent preoperative echocardiography
(transthoracic (TTE) and/or transesophageal (TEE)) and
coronary angiography. TTE accurately revealed the
diagnosis of PMR in 18 patients. PMR was suspected in
the remaining 30 patients and confirmed with TEE in
24 patients. In 6 patients the exact mechanism of MR
remained inconclusive. Left ventricular function was
assessed by echocardiography. In addition, wall motion
abnormalities were documented for infarct localization.
Surgical technique
Surgical data is summarized in Table 2.
Patients were considered to undergo a salvage operation
when brought to the operating room under cardiopulmo-
nary resuscitation, an emergency operation when brought
to the operating room directly from the catheterization lab
or intensive care unit because of haemodynamic instability,
and an urgent operation when operated on during the same
hospitalization as for angiography because their dischargewas deemed medically unreasonable [18]. Otherwise the
operation was considered elective.
PMR was confirmed during surgery in all patients.
When a papillary muscle (PM) was divided into several
heads, rupture of a single head was defined as “partial”
[12,13]. In case of detachment of the main insertion of a
head which still remained fixed to the remnant PM via
muscular bridges, rupture was defined as “incomplete”
[12,13]. Rupture of the whole PM was defined as “total
and complete” [12,13].
Myocardial protection was carried out using moderate
systemic hypothermia and antegrade or combined ante-
grade and retrograde cardioplegia. The mitral valve was
exposed with a left atriotomy or a transseptal approach
(or with a left ventriculotomy in one patient with a
ventricular septal rupture). Surgeon’s choice dictated
treatment strategy. Repair techniques are shown in
Table 2. Concomitant procedures were performed in
28 patients and concomitant coronary artery bypass
grafting (CABG) was performed in 24 patients (Table 2).
After weaning from cardiopulmonary bypass mitral valve
competence was confirmed with TEE.
Patients who underwent mitral valve repair or MVR
with a bioprosthesis received acenocoumarol treatment
for 3 months and patients who underwent MVR with a
mechanical prosthesis were put on lifelong acenocou-
marol treatment. In addition, patients who underwent
concomitant CABG also received lifelong acetylsalicylic
acid treatment.
Statistics
Continuous variables were expressed as mean ± standard
deviation. Categorical variables were expressed as per-
centages. Comparisons between groups for univariate
analysis of in-hospital mortality were performed using
Pearson`s χ2 test or Fisher’s exact test (two-sided) as
appropriate for categorical variables and the independent
samples t-test or Mann–Whitney U test (two-sided) as
appropriate for continuous variables. Univariate variables
with P < 0.10 were included in the multivariate analysis.
Age and gender were included in all multivariate models,
irrespective of the results of univariate analysis. Multivari-
ate analyses were performed with the logistic EuroSCORE
(model 1), with the EuroSCORE II (model 2), and without
the EuroSCOREs (model 3). Multivariate logistic regres-
sion analyses by means of a forward stepwise algorithm
(cutoff for entry and removal set at a significance level of
0.05) were performed to identify independent predictors
of in-hospital mortality. Odds ratios were reported with
95% confidence intervals (CI). Goodness-of-fit of the
final logistic regression models was assessed with the
Hosmer-Lemeshow statistic.
Receiver operating characteristic (ROC) curves were
calculated for continuous independent predictors to single
Table 1 Preoperative patient data (n = 48)
Variablea Value





Class III 7 (15)
Class IV 41 (85)
EuroSCORE I (logistic),% 29.4 ± 22.7
EuroSCORE II,% 19.4 ± 14.6
Previous myocardial infarction 48 (100)
Inferior and/or posterior 32 (67)
Inferoposterolateral 13 (27)
Anterolateral 9 (19)
Coronary artery disease 48 (100)
Left main stenosis 3 (6)
One-vessel disease 23 (48)
Two-vessel disease 17 (35)
Three-vessel disease 8 (17)
Infarct related artery
Left anterior descending coronary artery 1 (2)
Left circumflex coronary artery 28 (58)
Right coronary artery 19 (40)
Previous percutaneous coronary intervention 12 (25)
Previous cardiac surgery 0 (0)
Preoperative grade of mitral regurgitation
3+ (moderate) 1 (2)
4+ (severe) 47 (98)
Preoperative LV function
Normal (EF >50%) 34 (71)
Moderately impaired (EF 30-50%) 10 (21)
Severely impaired (EF <30%) 4 (8)
Heart rhythm
Sinus rhythm 43 (90)
Atrial fibrillation 5 (10)
Pacemaker 0 (0)
Pulmonary artery pressure
Systolic/diastolic, mmHg 46 ± 13/25 ± 10
Mean, mmHg 32 ± 10
Pulmonary capillary wedge pressure, mmHg 24 ± 14
Mechanical ventilation 23 (48)
Inotropic drug support 26 (54)
Intra-aortic balloon pump 21 (44)
Serum creatinine, μmol/L 162 ± 100
Acute renal failure 10 (21)
Table 1 Preoperative patient data (n = 48) (Continued)
Cardiogenic shock 31 (65)
History of congestive heart failure 4 (8)
Hypertension 11 (23)
Diabetes mellitus 9 (19)
Smoking 16 (33)
Hypercholesterolemia 5 (10)
Obesity (body mass index >30 kg/m2) 7 (15)
Peripheral vascular disease 2 (4)
Family history of coronary artery disease 6 (13)
Chronic renal disease 1 (2)
Chronic obstructive pulmonary disease 2 (4)
Cerebrovascular disease 5 (10)
aData are presented as mean ± standard deviation or number (%).
EF: ejection fraction; LV: left ventricle; NYHA: New York Heart Association.
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mortality. The point with the largest sum of sensitivity
and specificity was chosen as a threshold. The area under
the curve (AUC) was estimated by the non-parametric
Wilcoxon-Mann–Whitney U statistic and standard error
(SE) was calculated with the method of DeLong and
Clarke-Pearson [19]. The statistical significance of dif-
ference of AUC from the “no discrimination line” was
evaluated by the Mann–Whitney U statistic.
All calculations were performed using commercially
available statistical packages (IBM SPSS Statistics 21.0;
IBM Corporation, Chicago, IL, USA and Stats Direct
2.8.0; StatsDirect Ltd, Cheshire, UK). Statistically signifi-
cant differences were established at P < 0.05.
Results
In-hospital mortality
Two patients died during surgery (intraoperative mortality
rate of 4.2%). One patient could not be weaned from
cardiopulmonary bypass and the other patient died due to
heart failure directly after weaning from cardiopulmonary
bypass. In addition to two intra-operative deaths, there
were another 10 postoperative deaths. In-hospital mortal-
ity was 25.0%. Causes of in-hospital death are shown in
Table 3.
Predictors of in-hospital mortality
Univariate and multivariate logistic regression analyses of
in-hospital mortality are shown in Table 4. Multivariate
analyses were performed with the logistic EuroSCORE
(model 1), with the EuroSCORE II (model 2), and without
the EuroSCOREs (model 3).
Model 1
Multivariate analysis with the logistic EuroSCORE
revealed the logistic EuroSCORE as an independent







Timing of mitral valve surgery
Surgery ≤7 days after MI 27 (56)
Surgery >7 days and ≤30 days after MI 9 (19)
Surgery >30 days after MI 12 (25)








PMPM and ALPM rupture (both complete) 1 (2)
Leaflet prolapse
AMVL prolapse 12 (25)
PMVL prolapse 15 (31)
AMVL and PMVL prolapse 21 (44)
Surgical approach
Left atriotomy 34 (71)
Transseptal 13 (27)
Left ventriculotomy 1 (2)
Mitral valve replacement 38 (79)
Mmechanical prosthesis 35 (92)
Bioprosthesis 3 (8)
(partial) preservation of the subvalvular apparatus 24 (63)
Mitral valve repair 10 (21)
Reimplantation of the PM in the LV wall and
annuloplasty ring (Carpentier-Edwards Classic)
1 (10)
Reimplantation of the PM in the corresponding PM with a
sandwiched pledget-reinforced PTFE suture and annuloplasty
ring (Carpentier-edwards Classic or Physio II
2 (20)
Quadrangular resection of P2 and annuloplasty ring
(Carpentier-Edwards Classic or Carbomedics)b
6 (60)
Commissuroplasty and annuloplasty ring
(Carpentier- Edwards Physio II)
1 (10)
Intraoperative mitral valve repair failure 1 (9)
Concomitant surgery 28 (58)
Coronary artery bypass grafting 24 (50)
Septal rupture closure 2 (4)
Aortic valve replacement 1 (2)
Tricuspid valve plasty 2 (4)
Table 2 Surgical data (n = 48) (Continued)
Duration of surgery, min 278 ± 88
Cardiopulmonary bypass time, min 178 ± 68
Aortic cross-clamp time, min 98 ± 36
Intraoperative IABP requirement 24 (50)
aData are presented as mean ± standard deviation or number (%).
bFailed in 1 patient intraoperatively and resulted in mitral valve replacement
(not counted as mitral valve repair).
ALPM: anterolateral papillary muscle; AMVL: anterior mitral valve leaflet; IABP:
intra-aortic balloon pump; LA: left atrium; LV: left ventricle; MI: myocardial
infarction; PMPM: posteromedian papillary muscle; PM(R): papillary muscle
(rupture); PMVL: posterior mitral valve leaflet; PTFE: polytetrafluorethylene.
Bouma et al. Journal of Cardiothoracic Surgery 2014, 19:171 Page 4 of 8
http://www.cardiothoracicsurgery.org/content/19/1/171predictor of in-hospital mortality (odds ratio 1.07 (95%
CI 1.03-1.12), Wald χ2 9.34, P = 0.002). The Hosmer-
Lemeshow goodness-of-fit test was non-significant,
indicating that this multivariate model is a good fit
(χ2 = 6.72, df = 7, P = 0.459). A receiver operating char-
acteristic (ROC) curve was calculated for the logistic
EuroSCORE to single out the optimal cutoff value of
predicting in-hospital mortality (Figure 1A). The optimal
cutoff value was 40% with an area under the curve (AUC)
of 0.85 (95% CI 0.71-1.00, P < 0.001), a sensitivity of 83.3%
and a specificity of 88.9%.Table 3 Postoperative patient data (n = 48)
Variable/Conditiona Value
Intraoperative mortality 2 (4)
Immediate postoperative grade of MR (TEE) (n = 46b)
0 (no or trace) 44 (96)
1+ (trivial) 2 (4)
Postoperative morbidity (n = 46b)
Re-exploration for bleeding 5 (11)
Re-exploration for cardiac tamponade 3 (7)
Prolonged inotropic support (>24 hours) 22 (48)
Prolonged respiratory support (>24 hours) 19 (41)
Post-operative hemodialysis 7 (15)
In-hospital mortalityc 12 (25)
Causes of in-hospital death (n = 12)c
Heart failure (unable to wean from CPB) 1 (8)
Heart failure 7 (58)
Septal rupture 1 (8)
Left ventricular rupture 1 (8)
Haemorrhagic shock (massive bleeding) 2 (17)
Total hospital stay, days 18.7 ± 15.5
Intensive care unit stay, days 9.7 ± 11.0
aData are presented as mean ± standard deviation or number (%).
bNumber of patients at risk left.
cIncludes intraoperative deaths.
CPB: cardiopulmonary bypass; MR: mitral regurgitation;
TEE: trans-esophageal echocardiography.
Table 4 Predictors of in-hospital mortality by univariate analysis and multivariate logistic regression analysis
Univariate analysis Multivariate analysis
Variable OR 95% CI P value OR 95% CI P value
Logistic EuroSCORE, % 1.08 (1.03-1.12) <0.001 1.07 (1.03-1.12) 0.002a
EuroSCORE II, % 1.12 (1.04-1.21) 0.001 1.12 (1.04-1.21) 0.003b
Preoperative LVEF <30% 11.67 (1.08-125.90) 0.043 − − −
Mechanical ventilation 4.71 (1.09-20.47) 0.030 − − −
Preoperative inotropic drug support 7.00 (1.34-36.69) 0.012 − − −
Acute renal failure 4.43 (1.00-19.58) 0.094 − − −
Cardiogenic shock 8.80 (1.03-75.55) 0.035 − − −
Salvage or emergent mitral valve surgery 8.80 (1.03-75.55) 0.035 − − −
Complete AL or PM PMR 4.55 (1.13-18.32) 0.041 6.51 (1.18-35.78) 0.031c
Mitral valve replacement 9.91 (0.54-182.88) 0.048 − − −
MVR without preservation of thesubvalvular apparatus 5.80 (1.41-23.84) 0.024 − − −
Cardiopulmonary bypass time, min 1.01 (1.00-1.02) 0.036 − − −
Intraoperative IABP requirement 19.46 (2.25-168.27) 0.001 18.70 (1.96-178.79) 0.011c
aModel 1; bModel 2; cModel 3.
AL: anterolateral; CI: confidence interval; IABP: intra-aortic balloon pump; LVEF: left ventricular ejection fraction; MVR: mitral valve replacement; OR: odds ratio;
PM: posteromedian; PMR: papillary muscle rupture.
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Multivariate analysis with the EuroSCORE II revealed
the EuroSCORE II as an independent predictor of
in-hospital mortality (odds ratio 1.12 (95% CI 1.04-
1.21), Wald χ2 8.82, P = 0.003). The Hosmer-Lemeshow
goodness-of-fit test was non-significant, indicating
that this multivariate model is a good fit (χ2 = 9.42,
df = 7, P = 0.224). A ROC curve was calculated for the
EuroSCORE II to single out the optimal cutoff value
of predicting in-hospital mortality (Figure 1B). The
optimal cutoff value was 25% with an AUC of 0.83
(95% CI 0.68-0.99, P = 0.001), a sensitivity of 83.3%
and a specificity of 86.1%.Figure 1 Receiver operating characteristic (ROC) curves. A: ROC curve
(optimal cutoff value 40%). B: ROC curve for the EuroSCORE II as a predictoModel 3
After removal of the EuroSCOREs from the model, com-
plete papillary muscle rupture (odds ratio 6.51 (95% CI
1.18-35.78), Wald χ2 4.64, P = 0.031) and intra-operative
IABP requirement (odds ratio 18.70 (95% CI 1.96-178.79),
Wald χ2 6.46, P = 0.011) were independent predictors of
in-hospital mortality. The Hosmer-Lemeshow goodness-
of-fit test was non-significant, indicating that this multi-
variate model is a good fit (χ2 = 0.40, df = 2, P = 0.818).
Discussion
PMR is a rare, but serious mechanical complication of MI,
which can lead to rapid clinical deterioration and deathfor the logistic EuroSCORE as a predictor of in-hospital mortality
r of in-hospital mortality (optimal cutoff value 25%).
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the optimal and most rational treatment for acute PMR,
but it still carries high risks [2,3,6,7]. In this study intra-
operative mortality was 4.2% and in-hospital mortality
was 25.0%. Other studies have shown similar short-term
mortality rates with intra-operative mortality ranging
between 0 and 6% and in-hospital mortality ranging
between 19 and 39% [7,14-17,20].
The logistic EuroSCORE and EuroSCORE II were
important independent predictors of in-hospital mortality
in this study. The logistic EuroSCORE is an important
risk-stratification model in cardiac surgery which was
introduced in 1999 [21]. The model was mainly designed
for predicting in-hospital mortality in CABG patients.
In the past decade the predictive power of the logistic
EuroSCORE has proven its value in research, clinical
practice and quality monitoring. In recent years, how-
ever, the predictive power of the logistic EuroSCORE
has declined (probably due to changes in populations
and improvement in surgical techniques and perioperative
care) with a relative overestimation of in-hospital mortality
in low-risk patients and a relative underestimation in high-
risk patients [22]. To more accurately predict in-hospital
mortality for patients undergoing a wider range of contem-
porary cardiac surgical procedures the EuroSCORE II was
introduced in 2012 [23]. In this study the mean logistic
EuroSCORE was 29.4% and the mean EuroSCORE II was
19.4%, which means that the logistic EuroSCORE over-
estimated and the EuroSCORE II underestimated the
actual in-hospital mortality rate in this cohort (25.0%).
Although both EuroSCOREs were not specifically designed
for patients undergoing mitral valve surgery for post-MI
PMR, these models can be used to predict in-hospital
mortality in this setting. ROC curve analysis showed that
the optimal cutoff value for reliably predicting in-hospital
mortality was 40% for the logistic EuroSCORE and 25%
for EuroSCORE II.
The posteromedian papillary muscle (PMPM) ruptures
3–12 times more frequently than the anterolateral papil-
lary muscle (ALPM) after MI [2,3,6,7]. The ALPM is less
vulnerable to rupture due to its dual blood supply from
the left anterior descending coronary artery and circum-
flex coronary artery [24]. The PMPM is more prone to
ischemia and rupture due to its dependence on single
blood supply from the posterior descending coronary
artery (which is either derived from the circumflex or
from the right coronary artery) [24]. In this study PMPM
rupture occurred in 42 patients (88%) and ALPM rup-
ture occurred in 5 patients (10%), which supports these
previous findings. Double PMR occurred in 1 patient
(2%). This study shows that ALPM rupture is usually
complete (80% of cases). PMPM rupture is usually partial
(59% of cases), due to the fact that the PMPM is fre-
quently subdivided into several heads [12,13]. Partial PMRcan lead to varying degrees of mitral regurgitation, but
complete PMR causes prolapse of both the anterior and
posterior leaflet and severe mitral regurgitation. Complete
PMR usually results in a more critical preoperative state
with imminent haemodynamic instability and cardiogenic
shock. In-hospital mortality was 42.1% for patients with
complete PMR and 13.8% for patients with partial or
incomplete PMR. Complete PMR was an independent
predictor of in-hospital mortality in this study.
Preoperative haemodynamic instability and cardiogenic
shock or difficulty to wean from CPB may warrant the use
of an intra-aortic balloon pump (IABP) to offload the left
ventricle by reducing afterload and improving coronary
perfusion [25]. Preoperative stabilization should not lead
to a false sense of security and delay of surgery, because
the subsequent course can be characterized by sudden
and unpredictable deterioration and progression to death
[2,3,6,7]. An IABP was required in 21 patients (44%) pre-
operatively. The IABP could be removed in 3 patients at
the end of the procedure. Another 6 patients required an
IABP intraoperatively. Therefore, intraoperative IABP
requirement was 50%. Similar to the findings reported in
several other studies [14,17], preoperative IABP require-
ment was not a predictor of in-hospital mortality in this
study. Intraoperative IABP requirement, however, was a
strong independent predictor of in-hospital mortality; with
an in-hospital mortality of 45.8% for patients who required
an IABP intraoperatively versus an in-hospital mortality of
4.0% for patients who did not require an IABP intraopera-
tively, P = 0.001. This finding highlights the negative im-
pact of immediate postoperative haemodynamic instability
on in-hospital mortality.
Although PMR can lead to rapid haemodynamic in-
stability, left ventricular ejection fraction (LVEF) appears
to be relatively preserved in patients requiring mitral
valve surgery for post-MI PMR [7,14]. The data from
this study supports that finding, since 71% of patients had
a normal LVEF (>50%), 21% had a moderately impaired
LVEF (30-50%), and only 8% had a severely impaired LVEF
(<30%). LVEF did not predict in-hospital mortality in our
study and several other studies [14,17]. A relatively pre-
served LVEF may result in greater shearing forces on the
ischemic PM, which may render it more prone to rupture
[3]. Preservation of LVEF may be related to limited infarct
size [7] and limited extent of coronary artery disease
(CAD) in this population [7,14]. Different studies have
shown a high incidence of one-vessel CAD in patients
requiring mitral valve surgery for post-MI PMR, ranging
from 23% to 44% [7,14]. This study supports these find-
ings with an incidence of one-vessel CAD of 48%.
The additional benefit of concomitant CABG in the
setting of mitral valve surgery for post-MI PMR remains
unclear. Two studies from the Mayo Clinic have shown
that concomitant CABG can improve immediate and
Bouma et al. Journal of Cardiothoracic Surgery 2014, 19:171 Page 7 of 8
http://www.cardiothoracicsurgery.org/content/19/1/171long-term survival [7,16]. Similar to the findings reported
in several other studies [15,17], concomitant CABG was
not a predictor of in-hospital mortality in this study.
In-hospital mortality was 20.8% in the concomitant
CABG group and 29.2% in the no concomitant CABG
group, P = 0.505. We also determined if revasculariza-
tion (with a preoperative percutaneous coronary inter-
vention (PCI) and/or with concomitant CABG) predicted
in-hospital mortality in patients undergoing mitral valve
surgery for post-MI PMR. 12 patients underwent a pre-
operative PCI (balloon angioplasty with or without
stenting); 24 patients underwent concomitant CABG (4
of these patients had also undergone a preoperative PCI).
In-hospital mortality was 21.9% in the revascularization
group and 31.3% in the no revascularization group,
P = 0.500. Revascularization did not predict in-hospital
mortality. At this point, there are no randomized studies
to determine the importance of concomitant CABG in
this setting. Concomitant CABG may improve postopera-
tive LV function and survival, but these potential benefits
have to be weighed against the consequences of prolong-
ing the duration of cardiopulmonary bypass (CPB). CPB
time was a predictor of in-hospital mortality (but not an
independent predictor) and mean CPB time was signifi-
cantly longer in patients who underwent concomitant
CABG (207 minutes) versus no concomitant CABG
(149 minutes), P = 0.002. A hybrid approach with mitral
valve surgery followed by PCI, if required, or preoperative
PCI of the infarct-related artery (culprit lesion) followed
by mitral valve surgery might be useful alternative strat-
egies. Especially because the percentage of patients with
single vessel CAD is high in this population; 48% in our
study and 23-44% in other studies [7,14]. Randomized
studies would have to identify whether such hybrid
approaches are superior to concomitant CABG in the
setting of post-MI PMR.
When post-MI PMR is complete, repair is often not
possible or advisable because of friable infarcted tissue
[7,12,15,16]. Mitral regurgitation secondary to partial or
incomplete PMR with limited adjacent tissue damage is
often amenable to a reliable repair, provided established
repair techniques are used and adjacent tissue is not fri-
able [7,8,10-13,16,26]. All 10 repair patients in this study
experienced partial or incomplete PMR. (Ischemic) PMR
is one of the rare conditions in which several Carpentier
functional types of regurgitation (type I, annular dilatation,
type II leaflet prolapse, and type IIIb restricted leaflet
motion) can more or less coexist [26], which is important
to realize during repair. In-hospital mortality was 0.0%
in the repair group versus 31.6% in the replacement
group, P = 0.048. MVR was not an independent predictor
of in-hospital mortality. MVR without preservation of the
subvalvular apparatus (i.e. with disruption of valvular-
ventricular or papillary muscle-annular continuity) wasassociated with a higher in-hospital mortality (50.0% for
MVR without preservation of the subvalvular apparatus
versus 20.8% for MVR with preservation of the subvalvu-
lar apparatus, P = 0.081; or versus 14.7% for the combined
group with a preserved subvalvular apparatus (repair or
MVR with preservation of the subvalvular apparatus),
P = 0.024), but it was not an independent predictor of in-
hospital mortality. In general it has been shown that MVR
with preservation of the subvalvular apparatus maintains
postoperative LV contractile function and improves out-
come [9]. As shown in this study, preservation of the sub-
valvular apparatus in MVR for post-MI PMR also seems
to have a beneficial influence on in-hospital mortality.
Limitations of this study include the retrospective
design, the long time frame, and the relatively small
number of patients. However, compared to the previ-
ously published literature on this subject this is one of
the largest published cohorts that underwent mitral valve
surgery for post-MI PMR. Future (multicenter) investi-
gations should include larger (preferably randomized)
cohorts to more accurately identify independent predic-
tors of short- and long-term outcome and to determine
outcome benefits of mitral valve repair versus replacement
for post-MI PMR.
Conclusions
Our findings indicate that the logistic EuroSCORE (optimal
cutoff ≥40%), EuroSCORE II (optimal cutoff ≥25%), com-
plete PMR, and intraoperative IABP requirement are strong
independent predictors of in-hospital mortality in patients
undergoing mitral valve surgery for post-MI PMR. These
predictors may aid in surgical decision making and they
may help improve the quality of informed consent.
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